FDA probes deaths of two patients on Lilly schizophrenia drug

(Reuters) - The U.S. Food and Drug Administration on Tuesday said it was investigating the deaths of two patients who died following injections with Eli Lilly and Co's long-acting treatment for schizophrenia, called Zyprexa Relprevv.

http://feedproxy.google.com/~r/reuters/healthNews/~3/VgBInlZn0vc/story01.htm

Source: Reuters: Health - June 18, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

More News: Food and Drug Administration (FDA) | Health | Schizophrenia | Zyprexa